Moving a mass spectrometry method from biomarker discovery toward clinical use takes more than sensitivity. Laboratories need to manage complex biological matrices, control workflow variability, and demonstrate reproducible performance.
This eBook brings together expert perspectives and technical insights on those challenges. Explore assay validation, quality assurance, and the potential of ion mobility, chromatography-free analysis, artificial intelligence, and proteoform characterization.
Download to discover approaches that support reliable measurements, faster workflows, and deeper insight into disease biology.
What You’ll Learn
- Advance biomarkers toward clinical use: Explore how study design, automated sample preparation, peptide standards, and auditable reporting support assay development and transfer.
- Understand exosome assay validation: Examine LC–MS/MS and immunoassay approaches, analytical performance characteristics, and QA/QC strategies for exosome biomarkers.
- Strengthen metabolomics workflows: Learn how system performance checks, chromatographic selectivity, and trapped ion mobility spectrometry (TIMS) influence data quality and identification confidence.
- Assess chromatography-free analysis: Discover where DART mass spectrometry could simplify workflows and increase throughput in clinical research and non-clinical testing.
- Explore AI-assisted data review: Examine applications in newborn screening, therapeutic drug monitoring, and toxicology, alongside validation needs and the role of expert judgment.
- Investigate disease-associated proteoforms: Hear how Direct Mass Technology supports antibody profiling and sequencing, opening new research directions in neuroinflammation and disease biology.
Use these insights to evaluate emerging technologies and strengthen the analytical foundations of clinical mass spectrometry.